AccessLange: General Ophthalmology / Printed from AccessLange (accesslange.accessmedicine.com).
 
Copyright ©2002-2003 The McGraw-Hill Companies. All rights reserved.
 

Printable VersionPrint this Page
 
Chapter 23: Blindness
Author: John P. Whitcher

Blindness


In this chapter we shall discuss blindness as a worldwide health problem, summarizing information about its epidemiology, emphasizing the value of community-based methods to prevent or treat its causes, and outlining resources available in more developed countries for rehabilitation of the blind. All of the disorders that may cause blindness are discussed more fully in other parts of this book.

DEFINITION OF BLINDNESS

The World Health Organization defines visual impairment as shown in Table 23-1. World Health Organization (WHO) officials encourage investigators and reporting agencies in all countries to report blindness and near blindness according to the categories defined in this table.

Table 23-1: Categories of visual impairment. (Adapted from the International Classification of Diseases, World Health Organization, 1977.)


In the USA, the most widely used definition of partial blindness is that used by the Internal Revenue Service for the purpose of determining who is eligible for tax deductions on that basis: central visual acuity 20/200 or less in the better eye with best correction, or widest diameter of visual field subtending an angle of no greater than 20 degrees. An alternative functional definition is loss of vision sufficient to prevent one from being self-supporting in an occupation, making the individual dependent on other persons, agencies, or devices in order to live.

"Industrial blindness" is said to be present when a worker can no longer pursue an occupation because of poor vision; "automobile blindness" when vision is so poor that the responsible licensing agency in that state will not issue a driver's license. The term color blindness is a misnomer since this genetically transmitted disorder is not blindness as that term is generally understood and is only a minor handicap to a few people. Loss of vision may affect only the central fields, only the peripheral fields, or only specific portions of the peripheral fields in one or both eyes. Total loss of vision in one eye is said to reduce visual capacity by only 10%, though it makes the other eye infinitely more valuable.

PREVALENCE OF BLINDNESS THROUGHOUT THE WORLD

WHO estimates that there are between 27 and 35 million blind people in the world today. This figure rises to at least 42 million if the criterion is extended to visual acuity of 20/200 or worse. Even where health statistics are most reliable, the methods of counting the blind are often crude and may be applied according to different criteria in different places and at different times within any extensive geographic area. Furthermore, extrapolations are often made from small sample studies to large populations. Ninety percent of the world's blind live in developing countries, mostly in Asia (approximately 20 million) and Africa (approximately 6 million), clustered largely in disadvantaged communities in rural areas and urban slums. The risk of blindness in many of these neglected communities is 10-40 times higher than in the industrially developed regions of Europe and America.

Table 23-2 lists some countries where fairly reliable data are available about the prevalence of blindness.

Table 23-2: Approximate prevalence of blindness (%) (Estimates based on WHO surveys.)1


CAUSES OF BLINDNESS & METHODS OF PREVENTION & TREATMENT

The relative importance of various causes of blindness differs according to the level of social development in the geographic area being studied. In developing countries, cataract is the leading cause, with trachoma, leprosy, onchocerciasis, and xerophthalmia also being important. In more developed countries, blindness is to a great extent related to the aging process. Cataract is still important despite the availability of facilities for its treatment, along with age-related macular degeneration and glaucoma. Other causes are diabetic retinopathy, herpes simplex keratitis, retinal detachment, and inherited retinal degenerative disorders.

In terms of the worldwide prevalence of blindness, the vastly greater number of people in the developing world and the greater likelihood of their being affected mean that the causes of blindness in those areas are numerically more important. Cataract is responsible for an estimated 17 million cases of blindness, trachoma between 6 and 9 million, leprosy at least 1 million, and onchocerciasis 1 million. Xerophthalmia is estimated to affect 5 million children each year; 500,000 develop active corneal involvement, and half of these go blind.

WHO estimates that up to 80% of cases of blindness in developing countries are avoidable, ie, preventable or treatable. The worldwide eradication of smallpox demonstrates what can be achieved in the area of infectious disease and the superiority of prevention over treatment. Similar efforts are being made to prevent the infectious diseases trachoma, leprosy, and onchocerciasis as well as the noninfectious xerophthalmia. The sheer numbers of individuals blinded by cataract continues to overwhelm the resources available. In all programs to reduce blindness in the developing world, cooperation between governments and nongovernmental charitable organizations has proved to be essential. The WHO Prevention of Blindness Programme has established centers in about 60 developing countries to undertake collaborative studies, particularly generating epidemiologically sound information to form the basis for rational planning, implementation, and proper evaluation of programs for prevention of blindness.

In more developed countries, the causes of blindness are less amenable to prevention. In general, it is necessary to rely on recognition and treatment of the early stages of the disease. This depends on education of ophthalmologists, nonophthalmologic medical personnel, and lay people about the necessity for screening for glaucoma and diabetic retinopathy and about the importance of the early symptoms of retinal detachment, age-related macular degeneration, and herpes simplex keratitis. The inherited conditions are amenable to prevention by genetic counseling.

Cataract

Cataract accounts for at least 50% of cases of blindness worldwide. As life expectancy increases, there is a continuing rise in the total number of people affected. In many parts of the developing world, the facilities available for treating cataract are grossly inadequate, hardly sufficient to cope with the new cases arising and completely inadequate for dealing with the backlog of existing cases, which is conservatively estimated to be 10 million worldwide.

It is not clearly understood why the frequency of cataract in different geographic areas varies so greatly, though exposure to ultraviolet radiation and recurrent episodes of dehydration, such as occur in severe diarrheal diseases, are thought to be important. If medical means could be found to delay the development of cataract by 10 years, it is estimated that this would reduce the number of individuals requiring surgery by 45%.

Mobile eye camps have aided in management, but there are too few to control the disorder. Many more cataract surgeons are needed in countries such as India and Pakistan. In a number of blindness surveys, the problem of uncorrected aphakia is particularly apparent. It has been suggested that intraocular lens implantation at the time of surgery, though requiring greater expertise, may be a better solution than relying on the subsequent provision of spectacles.

Trachoma

Trachoma causes bilateral keratoconjunctivitis, generally in childhood, that leads in adulthood to corneal scarring, which, when severe, causes blindness. About 400 million people have trachoma, most of them in Africa, the Middle East, and Asia. Trachoma can be treated with sulfonamides or various antibiotics such as tetracyclines or erythromycin and related agents, and an estimated 60 million individuals currently require treatment. But prevention of spread of infection by provision of proper sanitary facilities, including clean water for drinking and washing, is more effective in eliminating the disease.

Leprosy

Leprosy (Hansen's disease) affects 15-16 million people in the world and has a higher percentage of ocular involvement than any other systemic disease. Up to 10% of leprosy patients are blind from the disease. The social stigma attached to leprosy has greatly hindered its treatment, but there are effective chemotherapeutic agents and the possibility of a vaccine.

Onchocerciasis

Onchocerciasis is transmitted by bites of the blackfly, which breeds in clear running streams (hence the name river blindness). It is endemic in the greater part of tropical Africa and Central and South America. The most heavily infested zone is the Volta River basin, which extends over parts of Dahomey, Ghana, Ivory Coast, Mali, Niger, Togo, and Upper Volta. Worldwide, 28 million people are affected by onchocerciasis, with 20% of individuals in endemic areas being blind from the disease.

The major ophthalmic manifestations of onchocerciasis are keratitis, uveitis, retinochoroiditis, and optic atrophy. The disease is prevented by insect eradication and personal protection by screening. Treatment is with ivermectin.

Xerophthalmia

Xerophthalmia is due to hypovitaminosis A. Clinically, there is xerosis of the conjunctiva with characteristic Bitot's spots and softening of the cornea (keratomalacia), which may lead to corneal perforation. Protein malnutrition exacerbates the condition and renders it refractory to treatment. Xerophthalmia is a common cause of blindness in infants, particularly in India, Bangladesh, Indonesia, and the Philippines. Affected infants often do not reach adulthood, dying from malnutrition, pneumonia, or diarrhea.

Xerophthalmia can be prevented by general dietary improvement or vitamin A supplementation. If the problems of distribution and administration were solved, the cost of a quantity of the vitamin sufficient to prevent blindness in 1000 infants would be only about $25.00.

Other Causes

Glaucoma, retinal detachment, diabetic retinopathy, and herpes simplex keratitis are discussed in greater detail elsewhere in this text. The incidence of blindness due to glaucoma has decreased in recent years as a result of earlier detection, improved medical and surgical treatment, and a greater awareness and understanding of the disorder by the lay population.

Diabetic retinopathy is an increasingly more common cause of blindness everywhere in the world. Recent advances in surgical treatment (vitrectomy, laser therapy) are of some help, but many patients still suffer from proliferative retinopathy, recurrent vitreous hemorrhages, and eventual bilateral blindness. A vast research effort directed at all aspects of diabetes is in progress, and there is justification for hoping that the next generation of diabetics will benefit greatly from what is being done now.

Hereditary conditions are important causes of blindness but should gradually decrease in incidence in response to the efforts of genetic counselors to increase public awareness of the preventable nature of these disorders.

As is true also in other countries where medical care and social services are widely available, blindness in the USA is to a great extent related to the aging process, and about half of the legally blind people in this country are over age 65. The leading causes of blindness in this age group are degenerative retinal disorders, glaucoma, diabetes, and vascular diseases.

COSTS OF AVOIDING BLINDNESS

Some examples of what can be achieved for modest outlays of scarce funds are as follows:

  1. To cure one person of trachoma in Saudi Arabia: $1.25.

  2. To restore vision to one person in India blinded by cataracts: $30.00.

  3. To prevent blindness due to xerophthalmia in one infant in Indonesia: 30 cents.

On the advice of WHO experts, the World Council for the Welfare of the Blind and several international professional ophthalmic societies and agencies agreed to take the initiative, which led to the establishment in 1974 of the International Agency for Prevention of Blindness (Vision International), with Sir John Wilson, a blind barrister, as president. The aim of this agency is to work with groups formed for the purpose of preventing blindness. Its theme, Foresight Prevents Blindness, was brought into prominent display when WHO celebrated the first World Health Day on April 7, 1976. Its goal was stated as follows: "In every donor country during 1976, every family should be asked-in thanksgiving for sight-to give $10.00 to save the sight of its fellow countrymen or of the millions in the third world."

REHABILITATION OF THE BLIND

Although no completely reliable statistics are available, the most widely used estimates place the legally blind population of the USA at 2.24 per thousand (ie, approximately 500,000). Approximately 50,000 become legally blind annually, and many others have enough visual loss to constitute a serious employment problem.

Blindness does not necessarily imply helplessness. Individual adjustment to marked visual impairment or total blindness varies with age at onset, temperament, education, economic resources, and many other factors. The older patient, for example, may accept blindness quite stoically, whereas for the younger patient the vocational or social impact of blindness is often catastrophic. Blindness is accepted more easily by persons who are born blind and by persons of any age who lose their vision gradually rather than suddenly.

The aim of rehabilitation is to enable the patient to lead as nearly normal a life as possible. Approximately 5000 blind persons in the USA are rehabilitated and obtain paid employment each year. An additional larger number of blind homemakers are able to perform their household duties without assistance or are able to live independently of others.

Rehabilitation must be individualized. Many special services (see Appendix III) and increasingly complex optical and nonoptical aids (see Chapter 22) are available, but they are not universally helpful. Different categories of the blind have different needs, and some blind people simply cannot benefit from a number of services or aids available. It has been said that over half of the blind people in the USA are over age 65. The elderly widowed housewife may need or want no more than mobility training in home care and a steady supply of Talking Books. A young person facing blindness in later life due to retinitis pigmentosa requires the full range of social services, including educational assessment, job rehabilitation, and psychologic counseling as well as a number of sophisticated aids.

The responsibility of the physician clearly does not end with the diagnosis, prevention, and treatment of ocular disorders that might result in blindness. The physician caring for the patient who is suddenly faced with actual or imminent blindness is in a position to be of great assistance. When blindness is a possibility but is not inevitable (eg, during acute ocular inflammation), optimism and reassurance are warranted. However, it is unwise to offer false hope or to delay "breaking the news" when blindness is inevitable. If it is certain that blindness will occur, it is important to extend to the distraught patient as well as to the patient's family the warmth, understanding, encouragement, and assistance so desperately needed. The physician should be alert to the severe depressive reactions that may occur.

It is especially important to assist the patient in making the adjustment to blindness while some vision is still present. Early referral to rehabilitation agencies is essential for recently blinded adults and those with irreversible progressive visual loss. Training programs or reeducation for the many changes involved in daily living and employment are greatly simplified if the patient has the partial support provided by even limited vision.

The physician should work actively with both the patient and the family and with other professional people concerned with rendering services to the blind. The physician must know what referral sources are available and how to use them skillfully. Medical social workers, public health nurses, and counseling services and agencies serving the blind and visually handicapped are common sources of reliable information. It may be valuable to have the patient talk with a blind person who has made a satisfactory adjustment to blindness.

Mobility Training & Guide Dogs

Mobility training is most important in rehabilitation of the blind. Many state commissions for the blind offer a wide variety of mobility training courses, either directly or in cooperation with private agencies. The courses are offered on an outpatient and residential basis and have varied objectives according to the special needs of the people who apply for help. The curriculum commonly includes self-care, home functions, and mobility within the community. Several universities * have undergraduate and postgraduate programs in mobility training for the blind.

The usefulness of guide dogs is limited by their daily care needs and the physical strength required to hold them in check. They are most useful for students and professional men and women in good health who lead fairly well organized lives. At this time, less than 2% of blind people in the USA use guide dogs. Sonar sensor canes may ultimately be a better answer to the mobility problem even for those who are now using a dog successfully.

Braille

This remarkably effective system of reading for the blind was introduced in 1825. The braille characters consist of raised dots arranged in two columns of three. The system is so simple that a blind child can quickly learn to read braille, and proficient readers can learn to read braille as fast as they can talk. The system has been adapted to musical notation and technical and scientific uses also. An international braille code was introduced in 1951.

Braille is used less commonly now than formerly, since many blind people prefer auditory aids both for informational and recreational purposes. But the recent availability of portable data storage systems with braille-encoded input and conventional or braille form printed output has brought about a resurgence of interest. Braille continues to be essential on tags attached to items in common personal use even for people who do not wish to use it for reading.

All paper money in the Netherlands and Switzerland is braille-printed to show the denomination.

Electronic Devices

Optacon is an electronic device that converts visual images of letters into tactile forms. It is easily portable and can be used with almost any kind of reading matter. Auditory aids are becoming increasingly important (eg, talking calculators, clocks, paper money identifiers).

FINANCIAL ASSISTANCE PROGRAMS

It is unfortunate that over half of the blind people in the USA are essentially dependent upon Social Security and whatever local supplemental aid may be available to them. For the younger blind population, rehabilitation programs are commonly administered at the state level by a division of the department of education specifically set up to serve blind people in the state. Some of these programs are better than others, and all physicians should support efforts to increase the effectiveness of such programs in their geographic area of influence. The programs are of wide scope and offer preliminary counseling followed by academic or vocational training as the circumstances warrant. Once a realistic vocational objective has been established, full financial support is commonly available. This single resource is probably the most crucial referral available to the ophthalmologist, particularly in the case of young patients. Counseling services are available as early as the junior high school years to ensure compliance with a curriculum consistent with measured aptitudes and interests. In many states, such rehabilitation programs as mobility training are administered under state auspices but contracted to private agencies for operational purposes.

In many countries, the blind receive no financial or other support from their governments and are either cared for by their families or left to manage by themselves in any way they can.

Special services available to the blind in the USA are listed and discussed in Appendix III.

*Undergraduate level programs are at Cleveland State University in Ohio, Florida State University in Florida, and Stephen F. Austin University in Texas. Graduate programs are available at Boston University, California State University (Los Angeles), Northern Colorado University, San Francisco State University, University of Arkansas, University of Wisconsin, and Western Michigan State University.

REFERENCES
 
Abiose A et al: Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Br J Ophthalmol 1994;78:8.  [ PMID 8110711 ]
 
Adeoye A: Survey of blindness in rural communities of South-Western Nigeria. Trop Med Int Health 1996;1:672.  [ PMID 8911452 ]
 
Courtright P et al: Multidrug therapy and eye disease in leprosy: A cross-sectional study in the Peoples Republic of China. Int J Epidemiol 1994;23:835.  [ PMID 8002199 ]
 
Dolin PJ et al: Reduction of trachoma in a sub-Saharan village in absence of a disease control programme. Lancet 1997;349:1511.  [ PMID 9167460 ]
 
Evans JG et al: Cost effectiveness and cost utility of preventing trachomatous visual impairment: Lessons from 30 years of trachoma control in Burma. Br J Ophthalmol 1996;80:880.  [ PMID 8976698 ]
 
Fielder AR et al: The management of visual impairment in childhood. Clin Develop Med 1993;128:1.
 
Foster A et al: Epidemiology of cataract in childhood: A global perspective. J Cataract Refract Surg 1997(23 Suppl)1:601.
 
Global scale of avoidable blindness. Lancet 1990;336:1038.  [ PMID 1977026 ]
 
Gulliford MC et al: Counting the cost of diabetic hospital admissions from a multi-ethnic population in Trinidad. Diabet Med 1995;12:1077.  [ PMID 8750217 ]
 
Lewallen S: Prevention of blindness in leprosy: An overview of the relevant clinical and programme-planning issues. Ann Trop Med Parasitol 1997;91:341.  [ PMID 9290840 ]
 
Lim AS: Mass blindness has shifted from infection (onchocerciosis, trachoma, corneal ulcers) to cataract. [Letter.] Ophthalmologica 1997;211:270.  [ PMID 9216023 ]
 
Lim ASM: Eye surgeons seize the opportunity. Am J Ophthalmol 1996;122:571.  [ PMID 8862055 ]
 
Moll AC et al: Prevalence of blindness and low vision of people over 30 years in the Wenchi District, Ghana, in relation to eye care programmes. Br J Ophthalmol 1994;78:275.  [ PMID 8199113 ]
 
Narita AS et al: Blindness in the tropics. Med J Aust 1993;159:416.  [ PMID 8377695 ]
 
Pitakiripan S et al: An outbreak of post-operative endophthalmitis in Lampang Hospital. J Med Assoc Thai 1995;78(Suppl 2):S95.  [ PMID 7561604 ]
 
The Prevention of Blindness: Report of WHO Study Group. World Health Organization Technical Report Series 518, 1973. [Entire issue.]
 
Rait JI: Seven million too many. Br J Ophthalmol 1996;80:385.  [ PMID 8695552 ]
 
Randy MJ et al: Blindness from uveitis in a hospital population in Sierra Leone. Br J Ophthalmol 1994;78:690.  [ PMID 7947548 ]
 
Robin AL et al: A long-term approach to eliminate cataract blindness. [Editorial.] Ophthalmology 1997;104:571.  [ PMID 9111247 ]
 
Schwab L et al: The epidemiology of trachoma in rural Kenya: Variation in prevalence with lifestyle and environment. Study Survey Group. Ophthalmology 1995;102:475.  [ PMID 7891988 ]
 
Sekhar GC et al: Ocular manifestations of Hansen's disease. Doc Ophthalmol 1994;87:211.  [ PMID 7835191 ]
 
Smith AF et al: The economic burden of global blindness: A price too high! Br J Ophthalmol 1996;80:276.  [ PMID 8703872 ]
 
Taylor HR et al: Increase in mortality associated with blindness in rural Africa. Bull WHO 1991;69:335.
 
Thylefors B et al: Developments for a global approach to trachoma control. Rev Int Trachom 1994;71:63.
 

List of Tables

new window Table 23-1: Categories of visual impairment. (Adapted from the International Classification of Diseases, World Health Organization, 1977.)
new window Table 23-2: Approximate prevalence of blindness (%) (Estimates based on WHO surveys.)1

 
 
 
 

10.1036/1535-8860.ch23

Copyright ©2002-2003 The McGraw-Hill Companies. All rights reserved.
Any use is subject to the Terms of Use and Notice. Additional credits and copyright information. For further information about this site contact tech_support@accessmedicine.com.
Last modified: October 17, 2002 .
McGraw-HillEducation
The McGraw-Hill Companies
AccessLange: General Ophthalmology / Printed from AccessLange (accesslange.accessmedicine.com).
 
Copyright ©2002-2003 The McGraw-Hill Companies. All rights reserved.